Compounded semaglutide and Wegovy contain the same active ingredient, and telehealth marketing leans hard on that fact. But same active ingredient is not the same as same medication, and understanding the gap is the single most useful thing you can do before choosing a GLP-1 provider.
What FDA Approval Actually Covers
An FDA-approved medication like Wegovy or Zepbound has been through clinical trials establishing safety and effectiveness at specific doses, and is manufactured under federal Current Good Manufacturing Practice requirements with batch-level quality controls. The FDA has reviewed the manufacturing process, the labelling and the trial data.
Compounded medications go through none of that. Compounding is a legitimate, long-standing pharmacy practice, but a compounded product is not evaluated by the FDA for safety, effectiveness or quality. Providers are required to disclose this, and the honest ones do so plainly. Gimme Care , for example, states its formulations are not FDA-approved and are not substitutes for Mounjaro, Zepbound, Wegovy or Ozempic.
FDA-Registered Is Not FDA-Approved
Some providers describe medication as produced in FDA-registered facilities. That means the facility is registered with the FDA, not that the medication has been approved. WellMedr uses exactly this phrasing while also stating its products are not FDA-approved. Both statements are true, and the distinction is easy to miss.
503A Versus 503B Compounding
503A Compounding Pharmacy
Compounds against individual patient prescriptions. Regulated primarily by state boards of pharmacy. Not required to follow federal Current Good Manufacturing Practice standards. The most common source in GLP-1 telehealth.
503B Outsourcing Facility
Registers with the FDA and produces in batches. Must follow Current Good Manufacturing Practice standards and is subject to FDA inspection. A meaningfully higher oversight bar, and less common in this market.
Neither produces an FDA-approved medication. But if you are going the compounded route, 503B sourcing puts your medication under federal manufacturing standards and FDA inspection rather than state pharmacy regulation alone. CoreAge Rx publishes 503B sourcing, and NexLife references both 503A and 503B among its named partners.
The Price Gap Has Narrowed Dramatically
Compounded GLP-1s became widespread because brand-name pricing was unreachable for self-pay patients. Manufacturer direct channels have changed that substantially.
| Option | Published Price | Regulatory Status |
|---|---|---|
| NovoCare Wegovy pill | $149 per month | FDA-approved |
| Compounded semaglutide, typical | $99 to $199 per month | Not FDA-approved |
| NovoCare Wegovy pen | $349 per month standard | FDA-approved |
| LillyDirect Zepbound 2.5 mg | $299 per month | FDA-approved |
| Compounded tirzepatide, typical | $133 to $250 per month | Not FDA-approved |
| LillyDirect Zepbound 7.5 mg+ | $699 per month | FDA-approved |
At the entry doses the gap is small. At higher tirzepatide doses it remains substantial.
The practical upshot: at low semaglutide doses, the FDA-approved pill can cost less than compounded alternatives. At higher tirzepatide doses, compounded remains considerably cheaper. Our cost guide works through the annual numbers.
What You Give Up With Compounded
- Verified potency: unless the provider publishes independent testing, as Healthon does, you are relying on the pharmacy's own controls
- Trial-backed dosing: compounded formulations have not been through the trials that established approved dosing schedules
- Consistent formulation: compounded products sometimes include additives like glycine or B12 that are not in the approved product
- Insurance coverage: insurers generally do not cover compounded medication at any provider
- Manufacturer support programs: savings cards and patient assistance apply only to brand-name products
What You Get With Compounded
- Lower cost at higher doses, sometimes dramatically so
- Access without insurance approval or prior authorization delays
- Flat-rate pricing at providers like Precision Telemed that does not rise with titration
- Microdosing options that are not available as approved products
- Faster starts, with several providers shipping within 24 to 48 hours of approval
How to Decide
Choose brand-name if
Regulatory certainty matters to you, you have insurance that might cover it, you are on a lower semaglutide dose where the price gap is small, or you want a product with trial-backed dosing.
Choose compounded if
You are self-pay at a higher dose where the gap is large, you want microdosing, you cannot get prior authorization approved, or you need to start quickly.
Either way, verify
Ask which pharmacy prepares compounded medication and whether it is 503A or 503B. Ask whether batches are independently tested. Providers that will not answer are telling you something.
Ask a clinician
Whether a compounded product is appropriate for you specifically is a clinical question, not a shopping one. It should be part of your consultation, not something you decide alone.
This Market Changes Fast
Regulatory positions on compounded GLP-1s have shifted repeatedly as drug shortages resolved, and manufacturer pricing has moved several times. Anything you read about this, here included, should be checked against current information before you act on it.
Frequently Asked Questions
Is compounded semaglutide the same as Wegovy?
No. They contain the same active ingredient, but Wegovy is FDA-approved and manufactured under federal standards with trial-backed dosing, while compounded semaglutide is prepared by a pharmacy and is not evaluated by the FDA for safety, effectiveness or quality.
Is compounded GLP-1 medication safe?
Compounding is a legitimate pharmacy practice, but compounded products do not carry FDA approval and quality depends on the compounding facility. That is why we weight pharmacy disclosure heavily in our compounded provider rankings . Whether it is appropriate for you is a clinical question for your prescriber.
What does 503B mean and why is it better?
A 503B outsourcing facility registers with the FDA, produces in batches, must follow Current Good Manufacturing Practice standards, and is subject to FDA inspection. A 503A pharmacy compounds per prescription under state regulation only. Neither produces FDA-approved medication, but 503B operates under stronger federal oversight.
Is brand-name always more expensive?
Not any more. The NovoCare Wegovy pill at $149 a month undercuts several compounded semaglutide programs. At higher tirzepatide doses, though, LillyDirect's $699 a month is far above compounded pricing, so it depends heavily on which medication and dose you need.
Can insurance cover compounded GLP-1s?
Generally no. Insurers do not typically cover compounded medications, which is why almost every compounded provider operates on a self-pay basis. Many accept HSA and FSA cards instead; see our insurance, HSA and FSA guide .
Why do compounded products sometimes include B12 or glycine?
Some compounding pharmacies add ingredients such as glycine or vitamin B12 to their formulations. VITAstir , for example, publishes a tirzepatide formulation with glycine and B12. These additions are not part of the FDA-approved product, and their effects have not been studied in the trials that supported approval.
Medical Disclaimer
This article is general information, not medical advice. GLP-1 medications are prescription drugs with real risks and contraindications, and only a licensed clinician who knows your history can decide whether one is appropriate for you. Prices, programs and policies described here reflect what providers published at the time of writing and change frequently; verify everything directly before enrolling. Read our full medical disclaimer.
Last reviewed: August 24, 2026